Belgium to reverse switch domperidone

8 May 2013 - Deborah Wilkes

Archived

All medicines containing domperidone – the active ingredient in Johnson & Johnson's Motilium – will be reverse-switched from non-prescription to prescription-only status in Belgium later this year.

Click tags below for more information on topics:

FAMHP

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: